InvestorsHub Logo
Followers 0
Posts 83
Boards Moderated 0
Alias Born 11/25/2016

Re: None

Friday, 03/24/2017 10:13:39 AM

Friday, March 24, 2017 10:13:39 AM

Post# of 38634
My Projections for three partner drugs are as follows;
drug sales | # comp | adjusted market | risk adjust 25% | not manufacturering 6% | manuf | %12
Seroquel 1000m ; 3 ; 333m ; 250m. ; N/a ; 35m
Lamictal. 519m. ; 16; 32m. ; 24m. ; 1.4m. ; 3.4m
Pristiq 889m ; 8; 111m. ; 83m. ; 5m. ; 12m

Seroquel per month May to November 35/12=2.9m if off by three then sales about $1m per month.

currently,losing $500k per month down from about $666k. Conclusion seroquel + additional adhd dosages will have us looking good in August timeframe. Agree the gap from May/June to when we get the royalty check is the issue.

I would have dilute 3m shares at 3 no warrants and stop this insanity of lack of strategic financial planning based on hope. We were around $3 long enough to tap the balance sheet off.

It does seem like 200k warrants were excericed so that should have brought in $500k since Feb. cash on hand was reported right?